Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus

ConclusionEarly clinical response between vancomycin- and ceftaroline-treated ABSSSIs was similar. Patients with ABSSSIs rarely remained hospitalized for> 2 –3 days, thus limiting our ability to critically assess clinical outcomes.Trial RegistrationClinicalTrials.gov identifier, NCT02582203.FundingAllergan plc.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research